FDA Panel Suggests Zero Tolerance For Blood Deposits On Jet Injectors
This article was originally published in The Pink Sheet Daily
Executive Summary
Felton International and PATH present disposable protector cap as a solution to cross contamination at the General Hospital and Personal Use Devices Panel meeting Aug. 9.
You may also be interested in...
Industry Proposes Retiring The Term “Recall,” But FDA Has Concerns
Medtronic VP Susan Alpert suggests renaming recalls "field safety corrective actions" in accordance with a recent Global Harmonization Task Force proposal. The issue was debated at an FDA/AdvaMed post-market workshop Feb. 9.
FDA Will Look At Risk Communications In Two Separate Assessments
Two studies are planned for 2006 to find out more about healthcare professionals' preferences for learning about medical risks.
TyRx Says Combination Products Offer Greater Opportunity Than Drug Delivery
The firm takes its first step toward launching an anesthetic surgical mesh product after shifting its focus from drug delivery to combination products.